Fox Chase Cancer Center

Articles

Fox Chase Cancer Center Scientist Yash Chhabra Honored With NextGen Stars Award From American Association for Cancer Research

January 23rd 2025

Yash Chhabra, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program, was recently honored with the American Association for Cancer Research’s NextGen Stars Award.

Fox Chase Cancer Center’s Roland Dunbrack Appointed Co-Leader of the Cancer Signaling and Microenvironment Program

January 21st 2025

Roland Dunbrack, PhD, of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was appointed co-leader of the program.

Fox Chase Cancer Center Welcomes Dr. Qing Chen

January 17th 2025

Qing Chen, MD, PhD, has joined as a new assistant professor in the Cancer Signaling and Microenvironment Research Program.

New Protocol Reduces Adverse Effects In Use of Key Drug for Multiple Myeloma

December 19th 2024

Fox Chase Cancer Center researchers have identified a pretreatment protocol that reduces adverse effects for the drug motixafortide.

Fox Chase Cancer Center’s Department of Clinical Genetics Expands Reach With Genetic Counseling and High-Risk Clinical Services at Chestnut Hill Hospital

December 6th 2024

Fox Chase Cancer Center is offering genetic counseling for those considered at high risk for breast cancer at Temple Health - Chestnut Hill Hospital.

Fox Chase Cancer Center’s Dr. Anthony M. Villano and Dr. Austin D. Williams Named Fellows of the American College of Surgeons

December 4th 2024

Fox Chase Cancer Center’s Anthony M. Villano, MD, FACS, and Austin D. Williams, MD, MSED, FACS, were named Fellows of the American College of Surgeons.

Fox Chase Cancer Center’s Dr. Richard J. Bleicher Appointed Vice Chair of the National Accreditation Program for Breast Centers and Chair of its Executive Committee

November 26th 2024

Richard J. Bleicher, MD, FACS, Chief of the Division of Breast Surgery and Clinical Director of the Breast Service Line at Fox Chase Cancer Center.

Fox Chase Cancer Center Researcher Lu Chen Receives $250,000 NIH Grant to Further Investigation of RNA

November 22nd 2024

Lu Chen, PhD, an Assistant Professor in the Nuclear Dynamics and Cancer Research Program has received a grant from the NIH to further investigate the role of RNA and the formation of liquid droplet structures within cancer cells.

Fox Chase Cancer Center Researcher Find New Treatment Targets in Microenvironment of Small Cell Lung Cancer

November 20th 2024

Parth A. Desai, MBBS, MD, was first author on a study that detailed significant findings in small cell lung cancer.

Fox Chase Cancer Center Researchers Find Differences in the Gut Microbiomes of Bladder Cancer Patients

November 14th 2024

A new study by researchers at Fox Chase Cancer Center and other institutions adds to that body of research, finding that there are significant differences in the microbiomes of patients who developed bladder cancer compared to those who were healthy.

Fox Chase Cancer Center’s Dr. Vanessa Wookey Presents Rectal Cancer Research at 24th Annual ECOG-ACRIN Young Investigator Symposium

November 13th 2024

Fox Chase Cancer Center’s Dr. Vanessa Wookey Presents Rectal Cancer Research at 24th Annual ECOG-ACRIN Young Investigator Symposium

Fox Chase Cancer Center Welcomes Lorenzo Galluzzi

November 8th 2024

Fox Chase Cancer Center is pleased to announce the hiring of Lorenzo Galluzzi, PhD, as an Associate Professor with tenure in the Cancer Signaling and Microenvironment Research Program.

Fox Chase Cancer Center’s Dr. Allision Aggon Receives Earth Angel Award From Breast Cancer Nonprofit Organization

October 24th 2024

Allison A. Aggon, DO, FACOS, of Fox Chase Cancer Center, was recently presented with an Earth Angel Award.

Fox Chase Cancer Center Becomes Philadelphia’s First Comprehensive Radiopharmaceutical Therapy Center of Excellence

October 17th 2024

Jian Q. “Michael” Yu, MD, FRCPC, FACNM, is Chief of Nuclear Medicine/PET at Fox Chase, which was recently named Philadelphia’s first Comprehensive Radiopharmaceutical Therapy Center of Excellence.

Fox Chase Cancer Center Researchers Propose a New Type of Sarcoma, PHF1::TFE3-Positive Fibromyxoid Sarcoma

October 15th 2024

A new study from researchers at Fox Chase Cancer Center has found that some ossifying fibromyxoid tumors are malignant sarcomas.

Fox Chase Cancer Center’s Daniel J. Campbell Receives Crystal Eagle Leadership Award From American Society for Healthcare Engineering

October 10th 2024

Daniel J. Campbell, TBE, CHFM, FASHE, received the Crystal Eagle Leadership Award from the American Society for Healthcare Engineering.

Fox Chase Cancer Center Welcomes Dr Alexander R. Vartanov

October 8th 2024

Fox Chase Cancer Center hired Alexander R. Vartanov, MD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

Fox Chase Cancer Center Welcomes Dr. Arielle S. Weiss

September 27th 2024

Arielle S. Weiss, MD, has joined Fox Chase Cancer Center as an assistant professor in the Division of Gynecologic Oncology in the Department of Surgery.

Fox Chase Cancer Center Researchers Examine Perceptions of Smoking Stigma Among African American/Black Populations

September 20th 2024

In research published in Nicotine & Tobacco Research, lead author Charnita Zeigler-Johnson, PhD, MPH, Associate Director of Community Outreach and Engagement, studied the prevalence of smoking stigma among the African American/Black community.

Fox Chase Cancer Center Welcomes Dr. Alycia So

September 19th 2024

Fox Chase Cancer Center has hired Alycia So, MD, as an assistant professor in the Division of Breast Surgery in the Department of Surgery.